SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-047687
Filing Date
2023-10-11
Accepted
2023-10-11 08:17:36
Documents
15
Period of Report
2023-10-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20011256x2_8k.htm   iXBRL 8-K 54241
2 EXHIBIT 3.1 ny20011256x2_ex3-1.htm EX-3.1 10614
3 EXHIBIT 3.2 ny20011256x2_ex3-2.htm EX-3.2 121073
  Complete submission text file 0001140361-23-047687.txt   360249

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyne-20231010.xsd EX-101.SCH 3862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20231010_lab.xml EX-101.LAB 23291
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20231010_pre.xml EX-101.PRE 16550
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20011256x2_8k_htm.xml XML 4396
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 231319458
SIC: 2834 Pharmaceutical Preparations